AlphaYouAD
Schedule 13G filing
Abu Dhabi Investment Authority cut its Eikon Therapeutics, Inc. (EIKN) stake below 5%
Abu Dhabi Investment Authority reported owning 2.1% of Eikon Therapeutics, Inc. (EIKN) (1,147,138 shares) in a Schedule 13G filed Oct 2, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 2, 2026
- Source
- Schedule 13G
More EIKN insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.